ATIVESITE | ASH in a Flash – Therapeutic Gene Editing of Stem Cells in Classical & Malignant Hematology
#ASHinaFlash, your fast track to essential #ASH24 content! Get expert highlights of must-see sessions and quick takes on the latest #hematology breakthroughs. Stay informed, fast!
Join the “Therapeutic Gene Editing of Stem Cells in Classical and Malignant Hematology” session at the 66th American Society of Hematology Annual Meeting and Exposition, where experts discuss groundbreaking advancements in gene editing technologies for hematologic applications. Dr. Justin Eyquem will showcase novel gene edits that enhance CAR T-cell persistence and introduce innovative vectors for in vivo CAR T-cell generation. Dr. Paulo Rio will reveal advancements in prime editing technology to correct hematopoietic stem cells (HSCs) in Fanconi Anemia patients, targeting long-term repopulating HSCs. Dr. Pietro Genovese will highlight the “epitope editing” strategy for acute myeloid leukemia (AML) immunotherapy, enabling precision targeting while minimizing off-tumor toxicities. Dr. Julia Skokowa will explore gene editing for severe congenital neutropenia and pre-leukemic syndromes, emphasizing safety and ethical considerations in these transformative therapies.
Session Details:
Date/Time: Sunday, December 8, 2024, 9:30 AM–11:05 AM PT
Location: Room 29, San Diego Convention Center
Co-Chairs: Dr. Marcela V. Maus (Harvard University/Massachusetts General Hospital) and Dr. Hannah Tamary (Sheba Medical Center, Tel Aviv University)
Learn more: hematology.org/Meetings/Annual-Meeting
Click in this link American Society of Hematology YouTube
